Witnessing the stock’s movement on the chart, on Thursday, Bausch Health Companies Inc (NYSE: BHC) had a quiet start as it plunged -1.20% to $6.57, before settling in for the price of $6.65 at the close. Taking a more long-term approach, BHC posted a 52-week range of $4.25-$8.69.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 52.33%. Meanwhile, its Annual Earning per share during the time was 52.33%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -3.99%. This publicly-traded company’s shares outstanding now amounts to $370.47 million, simultaneously with a float of $307.77 million. The organization now has a market capitalization sitting at $2.28 billion.
Bausch Health Companies Inc (BHC) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Bausch Health Companies Inc’s current insider ownership accounts for 11.44%, in contrast to 69.29% institutional ownership. According to the most recent insider trade that took place on Nov 25 ’25, this organization’s 10% Owner bought 2,500,000 shares at the rate of 6.25, making the entire transaction reach 15,625,000 in total value, affecting insider ownership by 73,255,869. Preceding that transaction, on Sep 08 ’25, Company’s EVP, General Counsel sold 13,370 for 7.31, making the whole transaction’s value amount to 97,735. This particular insider is now the holder of 499,585 in total.
Bausch Health Companies Inc (BHC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.7 per share during the current fiscal year.
Bausch Health Companies Inc’s EPS decrease for this current 12-month fiscal period is -3.99% and is forecasted to reach 4.17 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.44% through the next 5 years, which can be compared against the 52.33% growth it accomplished over the previous five years trading on the market.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
Let’s observe the current performance indicators for Bausch Health Companies Inc (BHC). It’s Quick Ratio in the last reported quarter now stands at 0.97. Alongside those numbers, its PE Ratio stands at $6.78, and its Beta score is 0.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.23. Similarly, its price to free cash flow for trailing twelve months is now 2.19.
In the same vein, BHC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.97, a figure that is expected to reach 1.21 in the next quarter, and analysts are predicting that it will be 4.17 at the market close of one year from today.
